Cite Filings / CTKB / 0000950170-22-004106

Feed Companies Filings Check

Sign in

10-K

Annual Report

Cytek Biosciences, Inc. Filed 2022-03-17 Acc 0000950170-22-004106

Documents 1

10-K Annual Report , ctkb-20211231.htm

Around this filing

2023-03-01 10-K Annual Report
2022-03-23 4 Chief Technology Officer sold 20,000 shares at $11.64 ($232,800)
2022-03-17 S-8 Securities Offered to Employees in Benefit Plans
2022-03-17 10-K Annual Report
2022-03-16 4 Director bought 583,870 shares at an average $12.31 ($7,188,926)
2022-03-14 SC 13D/A Beneficial Ownership Report
2022-03-11 4 Director bought 634,638 shares at an average $12.86 ($8,158,671)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading ctkb-20211231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…